Skip to content

Mathematically Arterialised Testing of Hypercapnic Subjects Study

A Prospective Observational Cohort Study to Investigate the Physiological Agreement Between Arterial Sampling (the Reference Method) and Mathematically Arterialised Venous Blood

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04072848
Acronym
MATHS
Enrollment
84
Registered
2019-08-28
Start date
2018-10-15
Completion date
2021-07-31
Last updated
2022-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercapnic Respiratory Failure

Brief summary

Prospective observational cohort study of patients admitted to hospital with suspected hypercapnic respiratory failure and requiring treatment with non-invasive ventilation (NIV) as part of standard, routine management. Contemporaneous blood gas samples will be obtained via arterial, capillary, and venous methods. The venous samples will undergo mathematical arterialisation via the v-TAC system. In line with standard medical care, arterial samples will be obtained before starting NIV and at two set points afterwards (day 1 post-NIV, and pre-discharge). Pre-existing clinical thresholds will be used to assess the reliability of v-TAC against ABG, the existing gold standard and will conduct a retrospective model of decision-making once the blood sampling component of the study is concluded.

Interventions

None listed

Sponsors

Aalborg University
CollaboratorOTHER
Papworth Hospital NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Aged 18 years or above. * Admitted for consideration of home Non Invasive Ventilation. * Due to undergo arterial blood gas sampling as part of routine clinical care

Exclusion criteria

* Inability to provide informed consent. * Clinical necessity to perform blood gas sampling prior to allowing sufficient time for informed consent. * Inability to obtain reliable SpO2 readings

Design outcomes

Primary

MeasureTime frameDescription
Change in blood carbon dioxide level (PaCO2)Between day 0 and day 1Change in PaCO2 between the pre-NIV (non-invasive ventilation) and day 1 NIV samples for ABG (arterial blood gas) versus v-TAC (arterialised venous blood gas)

Secondary

MeasureTime frameDescription
Change in PaCO2 between ABG versus v-TAC versus Capillary Blood Gas (CBG) versus Venous Blood Gas (VBG)Between day 0 and day 1Change in PaCO2 between ABG versus v-TAC versus Capillary Blood Gas (CBG) versus Venous Blood Gas (VBG) between the pre-NIV and day 1 samples
Relative difficult in samplingBetween day 0 and through to study completion, up to 3 daysFrequency of sampling error rate for ABG versus CBG versus VBG versus V-TAC
Patient experienceBetween day 0 and through to study completion, up to 3 daysUsing Numeric Pain Scale where 0 is no pain, 5 is moderate pain and 10 is worst pain possible
Patient preferenceBetween day 0 and through to study completion, up to 3 daysPatient preference for method of blood gas sampling will be recorded in medical records

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026